Close mobile menu×
Close mobile menu

Sharon L. Wardlaw, MD

Board Certifications: 
Endocrinology, Internal Medicine
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-2254

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor

Board Certifications

  • Endocrinology
  • Internal Medicine

Clinical Expertise

  • Neuroendocrinology
  • Pituitary Disease

Education & Training

  • Cornell University Medical College, NY
  • Residency: Case Western Reserve Medical Center
  • Fellowship: Columbia Presbyterian Medical Center, NY

Honors & Awards

  • 1983 Harold and Golden Lamport Research Award

About Sharon Wardlaw

Dr. Wardlaw is Professor of Medicine and the Robert C. and Veronica Atkins Professor of Obesity Research at the College of Physicians and Surgeons. Dr. Wardlaw is Director of the Neuroendocrine Unit at Columbia University College of Physicians and Surgeons. She is an active member of the Columbia University Diabetes and Endocrinology Research Center, the Institute of Human Nutrition and the New York Obesity Research Center. She has served on several NIH Study Sections and has been an appointed member of the Endocrinology Study Section and of the Integrative Physiology of Obesity and Diabetes Study Section.

She has served on the editorial boards of Neuroendocrinology and the Journal of Clinical Endocrinology and Metabolism and was also Associate Editor of the Journal of Clinical Endocrinology and Metabolism. She has published over 100 peer-reviewed articles in the fields of neuroendocrinology and obesity.

She participates in the teaching of medial students, residents and fellows and is Director of the Endocrinology Clinic. A major interest has been in career development and she has served on numerous Departmental, CUMC and University committees involved with faculty development and promotions. These include Co-Chair of the CUMC and Faculty of Medicine Committees on Appointments and Promotions, Co-Chair Department of Medicine Committee on Promotions, Columbia University Senate, Faculty Affairs Committee and CUMC Advisory Committee on Faculty Academic Tracks.

Academic Titles

  • Robert C. and Veronica Atkins Professor of Obesity Research in Medicine

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
180 Fort Washington Avenue
Suite 9-970
New York, New York 10032
Phone:
(212) 305-2254
Fax:
(212) 305-2282
Primary

Research

The Neuroendocrine Program encompasses basic and clinical research and provides specialized care to patients with hypothalamic and pituitary disorders. Dr. Wardlaw has done clinical neuroendocrine research for over 25 years ranging from studies of normal pituitary physiology to the diagnosis and treatment of pituitary diseases, including prolactinomas, acromegaly, Cushing's disease and lymphocytic hypophysitis. A major clinical and basic research interest has been in the stress response and the regulation of the hypothalamic-pituitary-adrenal (HPA) axis and of the ACTH precursor, proopiomelanocortin (POMC). An important research focus has been the regulation of POMC gene expression and peptide processing in the hypothalamus and on the physiology of the brain POMC-derived peptides, β-endorphin and α-MSH. Dr. Wardlaw was the first to show that POMC is regulated in hypothalamus by sex steroids in rodents and primates and that this is important in regulating the pituitary-gonadal axis. She has also demonstrated that POMC is regulated in the hypothalamus by glucocorticoids, opioids, dopamine and leptin. More recently Dr. Wardlaw has focused her basic research on the neuroendocrinology of obesity. Studies have centered on understanding how the brain senses levels of peripheral energy stores and integrates these signals to maintain energy balance. An exciting focus has been on the hypothalamic melanocortin system, which plays a critical role in maintaining energy balance in humans and animals. Dr. Wardlaw has shown in rodents, using pharmacological and transgenic models, that activation of the melanocortin system reduces body weight and adiposity and improves glucose metabolism, particularly in the setting of diet-induced obesity. These results suggest that long-term melanocortinergic activation could serve as a potential strategy for the treatment of obesity and its deleterious metabolic consequences. She has also shown that the melanocortin system plays an important role in modulating cytokine and neuroendocrine responses to inflammation in both rodent and primate models. Ongoing studies are characterizing the mechanisms by which the melanocortin system modulates energy expenditure, fuel oxidation and glucose metabolism in rodent models and are examining potential ways to safely activate this system for therapeutic benefit in the human. Dr. Wardlaw has helped to develop a clinical obesity research program to facilitate the translation of these animal studies to human obesity. Ongoing clinical studies are developing biomarkers to assess brain melanocortin activity in humans. Related clinical research focuses on understanding and reversing the neuroendocrine responses induced by weight loss in order to help maintain weight loss after dieting.

Research Interests

  • Neuroendocrine control of pituitary function
  • Hypothalamic regulation of energy homeostasis
  • Neuroendocrine-immune interactions

Grants

CSF NEUROPEPTIDE, HORMONAL AND METABOLOMIC ANALYSIS IN HUMAN ENERGY (Federal Gov)

Aug 1 2017 - Jul 31 2020

A NEW THERAPEUTIC OPTION FOR THE TREATMENT OF PROLACTINOMAS (Federal Gov)

Sep 16 2016 - Jun 30 2019

PROSPECTIVE STUDY OF CLINICALLY NON-FUNCTIONING PITUITARY ADENOMAS (Federal Gov)

Mar 1 2010 - Feb 28 2017

THE CENTRAL MELANOCORTIN SYSTEM AND REGULATION OF ENERGY BALANCE (Federal Gov)

Jan 1 2008 - Dec 31 2013

CEREBROSPINAL FLUID (CSF) NEUROPEPTIDE ANALYSES IN HUMAN OBESITY: STUDY OF MELANOCORTIN PEPTIDES AND NUTRIENT METQBOLITIES IN LEAN, OBESE AND WEIGHT-REDUCED SUBJECTS (Private)

Aug 13 2012 - Aug 12 2013

CEREBROSPINAL FLUID (CSF) NEUROPEPTIDE AND METABOLOMIC ANALYSES IN HUMAN OBESITY: STUDY OF MELANOCORTIN PEPTIDES AND NUTRIENT METABOLITIES IN LEAN, OBESE AND WEIGHT-REDUCED SUBJECTS (Private)

Aug 16 2010 - Dec 31 2012

EFFECTS OF EARLY ESTRADIOL REPLACMENT ON ADIPOSE TISSUE INFL AMMATION AND METABOLISM IN POSTMENOPAUSAL WOMEN (Private)

Jul 1 2010 - Jun 30 2012

EFFECTS OF SATURATED VERSUS UNSATURATED DIETARY FAT ON THE R ELEASE OF GUT HORMONES THAT REGULATE SAF (Private)

Mar 19 2007 - Jul 31 2011